Upregulation of VEGF in subchondral bone of necrotic femoral heads in rabbits with use of extracorporeal shock waves

被引:157
作者
Ma, Huan-Zhi [1 ]
Zeng, Bing-Fang [1 ]
Li, Xiao-Lin [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Orthoped Surg, Shanghai 200233, Peoples R China
关键词
extracorporeal shock wave treatment; osteonecrosis; subchondral bone; vascular endothelial growth factor (VEGF);
D O I
10.1007/s00223-007-9046-9
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Extracorporeal shock wave treatment appears to be effective in patients with avascular necrosis of the femoral bead. However, the pathway of biological events whereby this is accomplished has not been fully elucidated. The purpose of this study was to investigate the effect of extracorporeal shock waves on vascular endothelial growth factor (VEGF) expression in necrotic femoral heads of rabbits. VEGF expression was assessed by immunohistochemistry, quantitative real-time PCR, and Western blot analysis. The degree of angiogenesis was also assessed, as determined by the microvessel density (MVD), the assessment of which was based on CD31-expressing vessels. Bilateral avascular necrosis of femoral beads was induced with methylprednisolone and lipopolysaccharide in 30 New Zealand rabbits. The left limb (the study side) received shock wave therapy to the femoral head. The right limb (the control side) received no shock wave therapy. Biopsies of the femoral heads were performed at 1, 2, 4, 8, and 12 weeks. Western blot analysis and real-time PCR showed that shock wave therapy significantly increased VEGF protein and mRNA expression, respectively, in the subchondral bone of the treated necrotic femoral heads. Compared with the contralateral control without shock wave treatment, the VEGF mRNA expression levels increased to a peak at 2 weeks after the shock wave treatment and remained high for 8 weeks, then declined at 12 weeks, whereas the VEGF protein expression levels increased to a peak at 4 weeks after the shock wave treatment and remained high for 12 weeks. The immunostaining of VEGF was weak in the control group, and the immunoreactivity level in the shock-wave-treated group increased at 4 weeks and persisted for 12 weeks. The most intensive VEGF immunoreactivity was observed in the proliferative zone above the necrotic zone. At 4, 8, and 12 weeks after the shock wave treatment, MVD in subchondral bone from treated femoral heads was significantly higher than that in subchondral bone from untreated femoral heads. These data clearly show that extracorporeal shock waves can significantly upregulate the expression of VEGF. The upregulation of VEGF may play a role in inducing the ingrowth of neovascularization and in improving the blood supply to the femoral head.
引用
收藏
页码:124 / 131
页数:8
相关论文
共 38 条
[1]
INDUCTION OF GROWTH-PLATE CARTILAGE OSSIFICATION BY BASIC FIBROBLAST GROWTH-FACTOR [J].
BARON, J ;
KLEIN, KO ;
YANOVSKI, JA ;
NOVOSAD, JA ;
BACHER, JD ;
BOLANDER, ME ;
CUTLER, GB .
ENDOCRINOLOGY, 1994, 135 (06) :2790-2793
[2]
Shock wave application enhances pertussis toxin protein-sensitive bone formation of segmental femoral defect in rats [J].
Chen, YJ ;
Kuo, YR ;
Yang, KD ;
Wang, CJ ;
Huang, HC ;
Wang, FS .
JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (12) :2169-2179
[3]
Shock wave therapy for chronic Achilles tendon pain - A randomized placebo-controlled trial [J].
Costa, ML ;
Shepstone, L ;
Donell, ST ;
Thomas, TL .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2005, (440) :199-204
[4]
A prospective, randomised study to compare extracorporeal shock-wave therapy and injection of steroid for the treatment of tennis elbow [J].
Crowther, MAA ;
Bannister, GC ;
Huma, H ;
Rooker, GD .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2002, 84B (05) :678-683
[5]
The biology of VEGF and its receptors [J].
Ferrara, N ;
Gerber, HP ;
LeCouter, J .
NATURE MEDICINE, 2003, 9 (06) :669-676
[6]
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene [J].
Ferrara, N ;
CarverMoore, K ;
Chen, H ;
Dowd, M ;
Lu, L ;
OShea, KS ;
PowellBraxton, L ;
Hillan, KJ ;
Moore, MW .
NATURE, 1996, 380 (6573) :439-442
[7]
FIORELLI G, 1994, J BONE MINER RES, V9, P329
[8]
Vascular endothelial growth factor is expressed in human fetal growth cartilage [J].
Garcia-Ramirez, M ;
Toran, N ;
Andaluz, P ;
Carrascosa, A ;
Audi, L .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (03) :534-540
[9]
VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation [J].
Gerber, HP ;
Vu, TH ;
Ryan, AM ;
Kowalski, J ;
Werb, Z ;
Ferrara, N .
NATURE MEDICINE, 1999, 5 (06) :623-628
[10]
Angiogenesis and bone growth [J].
Gerber, HP ;
Ferrara, N .
TRENDS IN CARDIOVASCULAR MEDICINE, 2000, 10 (05) :223-228